Cardiotoxicity of T cell immunotherapies.

Saved in:
Bibliographic Details
Title: Cardiotoxicity of T cell immunotherapies.
Authors: Raddatz MA; UCLA Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of California, Los Angeles, CA, USA., Stein-Merlob AF; UCLA Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of California, Los Angeles, CA, USA., Mahmood SS; Catholic Health Cardio-Oncology Program, Division of Cardiology, Department of Medicine, St. Francis Medical Center, Roslyn, NY, USA., Ganatra S; Lahey Health Cardio-Oncology Program, Division of Cardiology, Department of Medicine, Lahey Hospital and Medical Center, Burlington, MA, USA., Addison D; Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA., Lin TL; UCLA Jonsson Comprehensive Cancer Center, Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, CA, USA., Larson SM; UCLA Jonsson Comprehensive Cancer Center, Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, CA, USA., Yang EH; UCLA Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of California, Los Angeles, CA, USA. ehyang@mednet.ucla.edu.
Source: Nature reviews. Cardiology [Nat Rev Cardiol] 2026 Feb 23. Date of Electronic Publication: 2026 Feb 23.
Publication Type: Journal Article; Review
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500075 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-5010 (Electronic) Linking ISSN: 17595002 NLM ISO Abbreviation: Nat Rev Cardiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1759-5010
DOI:10.1038/s41569-026-01265-z